FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

RPG LIFE SCIENCES LTD.

NSE : RPGLIFEBSE : 532983ISIN CODE : INE105J01010Industry : Pharmaceuticals & DrugsHouse : RPG Enterprises

BSE2198.6529.5 (+1.36 %)

PREV CLOSE (Rs.) 2169.15

OPEN PRICE (Rs.) 2178.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 882

TODAY'S LOW / HIGH (Rs.)2178.00 2251.50

52 WK LOW / HIGH (Rs.)1382.55 2976.7

NSE2188.8016.5 (+0.76 %)

PREV CLOSE( Rs. ) 2172.30

OPEN PRICE (Rs.) 2185.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 2188.80 (89)

VOLUME 21867

TODAY'S LOW / HIGH(Rs.) 2160.10 2257.00

52 WK LOW / HIGH (Rs.)1381 2974.95

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

19.61

Dividend Yield(%)

1.09

TTM EPS (Rs.)

110.79

P/E Ratio

19.84

Book Value (Rs.)

320.78

Face Value (Rs.)

MCap (Rs. in Mn)

36363.51

Price/Earning (TTM)

17.77

Price/Sales (TTM)

5.57

Price/Book (MRQ)

6.85

PAT Margin (%)

14.05

ROCE (%)

34.96

Incorporation Year : 2007

Management Info :

Harsh Goenka - Chairman Ashok Nair - Managing Director

Registered Office :

Address : R P G House , 463,Ceat Mahal,Dr. Annie Besant Road, Worli,
Mumbai,
Maharashtra-400030

Phone : 022 - 24981650 / 24986375

Email : info@rpglifesciences.com

Website : www.rpglifesciences.com

Registrars Details :

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

29Apr Appointment of Director
Inter alia, approved:- 1. Recommended of final dividend of Rs. 20 (Rupe..

11Apr RPG Life Sciences informs about compli
RPG Life Sciences has enclosed certificate dated April 03, 2025 issued b..

08Apr RPG Life Sciences informs about change
RPG Life Sciences has informed that on the recommendation of the Nominat..

Financials

	QTR Mar 25	ANNUAL 25
Net Profit	1173.5	1832.4
Gross Profit	1349	2328.8
Operating Profit	305.5	1723.3
Net Sales	1430.9	6534.3

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Emcure Pharma (BSE)

1288.65 (10.00%)

M.Cap (Rs. in Cr)24417.77

Medplus Health Servi (BSE)

950.90 (7.36%)

M.Cap (Rs. in Cr)11381.69

Shilpa Medicare (BSE)

781.50 (6.33%)

M.Cap (Rs. in Cr)7642.36

Orchid Pharma (BSE)

754.40 (4.21%)

M.Cap (Rs. in Cr)3826.25

Shareholding Pattern

	PROMOTERS	72.95%
	NON-INSTITUTION	21.47%
	MUTUAL FUNDS/UTI	3.53%
	FI/BANKS/INSURANCE	0.22%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

Quant Healthcare Fu...

9.28

Mirae Asset Multica...

1.26

Union Small Cap Fun...

0.88

Quant Active Fund(G)

0.43

Bandhan BSE Healthc...

0.08

Motilal Oswal BSE H...

0.08

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22